Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA
28 juin 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 28, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Upgrades Trading to the OTCQX Best Market
01 mars 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, March 01, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
UPDATE - Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements
22 févr. 2022 10h34 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements
22 févr. 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
16 févr. 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Dealer’s License Granted by Health Canada
07 févr. 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent
18 janv. 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Provides Dealer License Update and Comments on Health Canada’s Amendments to the Special Access Program (SAP)
05 janv. 2022 16h17 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
21 déc. 2021 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Requests Final Inspection for Dealer’s License
07 déc. 2021 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...